CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A safety study of ANK-700 in patients with relapsing remitting multiple sclerosis. The study has two parts:Part A - first in human ...
Phase 1
Tampa, Florida, United States and 14 other locations
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Tampa, Florida, United States and 72 other locations
will evaluate the pharmacokinetics, safety and tolerability, and immunogenicity of ocrelizumab administered subcutaneously to participants with multiple...
Phase 1
Tampa, Florida, United States and 20 other locations
purpose of the study is to evaluate the safety and tolerability of single ascending intravenous (IV) doses of RO7121932 in participants with multiple...
Phase 1
Tampa, Florida, United States and 23 other locations
and adolescents 10 to 17 years of age with relapsing forms of multiple sclerosis (MS).Secondary Objective:To assess the ef...
Phase 3
Tampa, Florida, United States and 54 other locations
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Tampa, Florida, United States and 32 other locations
Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...
Phase 3
Tampa, Florida, United States and 122 other locations
A single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis...
Phase 3
Tampa, Florida, United States and 20 other locations
This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...
Phase 4
Tampa, Florida, United States and 35 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Tampa, Florida, United States and 208 other locations
Clinical trials
Research sites
Resources
Legal